India

Patanjali Advertising Case: SC Grants Exemption To Baba Ramdev, Acharya Balkrishna

In a recent development regarding the Patanjali misleading advertising case, the Supreme Court has granted Baba Ramdev and Acharya Balkrishna an exemption from appearing in the next hearing.

However, the Court emphasized that this exemption applies only to the upcoming hearing and not beyond.

The Court took a stern stance against Baba Ramdev and Acharya Balkrishna for failing to submit the original copy of the apology published in newspapers.

Mukul Rohatgi, representing Baba Ramdev, stated during the hearing that they had submitted the apology paper to the registry.

The Court, however, questioned why the original records were not submitted and why e-filing was opted for instead.

Noting a serious lack of communication, the Supreme Court remarked on the apparent deliberate actions, acknowledging the astuteness of the lawyers involved.

Furthermore, Ramdev’s lawyer attributed the oversight to potential ignorance, to which the Court responded by appreciating their understanding of the significance of the matter.

The Court directed Baba Ramdev to submit only the newspaper publication and the date’s apology, scheduling the next hearing for May 14th.

During the proceedings, Mukul Rohatgi mentioned that the president of the Indian Medical Association (IMA) had given an interview. He raised questions about the Court’s comments from the previous hearing.

The Court instructed that the president’s statement should be formally put on record, highlighting the gravity of the matter.

Uttarakhand Authority Imposes Ban on 14 Products

Meanwhile, the state licensing authority has imposed a ban on 14 products from Patanjali Ayurved and Divya Pharmacy. This move follows the company’s dissemination of misleading advertisements about their products.

The Supreme Court further indicated that other companies engaged in misleading advertising would also be subject to investigation.

The Court’s inquiries extended to the actions taken by the central government against companies involved in deceptive advertising. It also questions the prescribing practices of allopathic doctors and the potential repercussions for knowingly prescribing expensive medicines.

Also Read: Uttarakhand CM Supports Locket Chatterjee During Nomination Filing

Mankrit Kaur

Recent Posts

Adani Portfolio Stocks Surge Up To 11%, Adani Green Energy Leads Rally

The total market value of Adani Portfolio increased by ₹9 lakh crore, reaching ₹393 lakh…

14 hours ago

Steve Smith Announces ODI Retirement After Australia’s Champions Trophy Exit

The Australian batter played 170 ODIs, scoring 5727 runs with 12 centuries. He won two…

15 hours ago

PM Modi Likely To Visit Sri Lanka In April On President Dissanayake’s Invitation

Prime Minister Narendra Modi is likely to visit Sri Lanka in the first week of…

15 hours ago

Delhi High Court To Hear Plea Against Batla House Demolition On March 5

The Dhobi Ghat Rights Forum filed the petition, demanding alternative land for Dhobi Ghat and…

16 hours ago

Patiala House Court Reserves Verdict On MP Rashid Engineer’s Interim Bail Plea

Patiala House Court has reserved its decision on MP Rashid Engineer’s interim bail plea. He…

16 hours ago

Unnao Rape Case: SC Questions Need For CRPF Security, Seeks Victim’s Response

The SC has given the last chance to the Unnao victim to respond to the…

16 hours ago